Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVDCF in Advanced Gastric Cancer
NCT00845884Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in gastric cancer (GC), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00845884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845884.